Well Told Grants

Federal grant recipients / South Carolina

Federal grants to Zylo Therapeutics, Inc.

Greenville, South Carolina · Small businesses · UEI RR11WNA1RBB3

Zylo Therapeutics, Inc. in Greenville, South Carolina received $3.2 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Diabetes, Digestive, and Kidney Diseases Extramural Research, with $2.0 million. In fiscal 2025 it was awarded $299,662.

From USAspending.gov award records, updated November 7, 2026.

By year

Federal grants to Zylo Therapeutics, Inc. by fiscal year
Fiscal yearAwardsAmount
FY 20211$697,168
FY 20223$1.6 million
FY 20232$447,861
FY 20241$145,888
FY 20251$299,662

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Zylo Therapeutics, Inc.

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Diabetes, Digestive, and Kidney Diseases Extramural Research 93.8472$2.0 million
Allergy and Infectious Diseases Research 93.8552$900,000
Arthritis, Musculoskeletal and Skin Diseases Research 93.8461$293,749

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services5$3.2 million

Largest awards

The 5 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
Development of microparticle-based topical treatments for treating erectile dysfunction in patients refractory to oral PDE5 inhibitors - abstract following radical prostatectomy (RP), virtually all men experience erectile dysfunction (ED), primarily due to damage to the cavernous nerve (CN). Yet, fi
ASST_NON_R44DK121587_075 on USAspending
Diabetes, Digestive, and Kidney Diseases Extramural ResearchJuly 19, 2021$1.7 million
Development and optimization of a nitric oxide releasing microparticle-basedtopical treatment for onychomycosis - onychomycosis is an extremely common and difficult-to-treat fungal nail infection that causes nail disfigurement, pain, associated infections, and psychosocial effects that negatively im
ASST_NON_R41AI165204_075 on USAspending
Allergy and Infectious Diseases ResearchAugust 18, 2022$600,000
Development and optimization of a nitric oxide releasing microparticle formulation for the topical treatment of chronic rhinosinusitis - chronic rhinosinusitis (CRS), defined by persistent inflammation and/or infection of the nasal cavity and paranasal sinuses, has a prevalence of 3.6% in the united
ASST_NON_R41AI188793_075 on USAspending
Allergy and Infectious Diseases ResearchSeptember 12, 2025$300,000
Development of an endocannabinoid microparticle formulation for the topical treatment of cutaneous manifestations of lupus erythematosus. - project summary/abstract approximately 500,000 people in the U.S. Suffer from cutaneous lupus lesions (CLE), with a significant impact on quality of life.4 yet,
ASST_NON_R41AR082749_075 on USAspending
Arthritis, Musculoskeletal and Skin Diseases ResearchMay 25, 2023$293,749
Optimization of a nanoparticle-based topical PDE5I formulation for treatment of erectile dysfunction - abstract it is increasingly recognized that erectile dysfunction (ED) not only affects a man’s sex life but also impacts his relationships and overall psychological well-being. An indication of the
ASST_NON_R41DK129147_075 on USAspending
Diabetes, Digestive, and Kidney Diseases Extramural ResearchSeptember 12, 2022$263,201

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Zylo Therapeutics, Inc. get?

$3.2 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Zylo Therapeutics, Inc. the most?

The Department of Health and Human Services, with $3.2 million in 5 awards.

What is Zylo Therapeutics, Inc.'s largest federal grant?

$1.7 million under Diabetes, Digestive, and Kidney Diseases Extramural Research, with its first action in the period on July 19, 2021. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Zylo Therapeutics, Inc.?

Its largest are Diabetes, Digestive, and Kidney Diseases Extramural Research, Allergy and Infectious Diseases Research and Arthritis, Musculoskeletal and Skin Diseases Research.

Other grant recipients in Greenville

Largest federal grant recipients in South Carolina · Federal grants in South Carolina